Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulforaphane in Chronic Kidney Disease
NCT05153174Phase 1Completed
- Sponsor
- University of Rochester
- Start
- May 2022
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sulforaphane in chronic kidney disease (CKD), sponsored by University of Rochester. Started May 2022; status: completed.
02
Drugs
sulforaphane
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT05153174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05153174.